UBS Asset Management is a global investment manager offering alternative and quantitative investments, global real estate, infrastructure & private equity, and fund services. It manages separate client-focused equity, fixed income, and balanced portfolios, investing in public markets worldwide using fundamental and quantitative analysis.
Chief Operations and Technology Officer and Member of the Group Executive Board
Dhun Davar
Head of Social Finance and India Head
Natalie Horton
Head of Global Markets Financing
Jesse Lane
Team Member
Hyunja Laski
Principal
Mark Mackenzie
MD - Private Placements
William Mathews
Global Head of Sales Trading
Paul McEwen
CIO Technology Services
Neal McMinn
Executive Director
Tom Naratil
Co-President Global Wealth Management and President UBS Americas
Steffan Peyer
Analyst Intern
Christopher Purves
Co-Head UBS Group Emerging Technology
Laurenz Simbruner
Associate Director
Todd Tuckner
CFO and Head Business Performance and Risk Management for Global Wealth Management
Patrick Yip
Associate
Past deals in Serbia
Swixx Biopharma
Debt Financing in 2021
Swixx Biopharma is a specialized company that provides comprehensive representation for biopharma, over-the-counter (OTC), and medical device firms in Central and Eastern Europe (CEE). Founded in 2014 and based in Baar, Switzerland, Swixx Biopharma operates fully-owned affiliates across various CEE countries, including Albania, Bulgaria, Poland, and Romania, among others. The company aims to fill the gap left by multinational corporations that choose not to enter or exit specific markets or therapeutic areas. With a focus on rare diseases, oncology-hematology, specialty treatments, and self-medication, Swixx Biopharma leverages its research expertise to deliver effective health solutions tailored to the needs of the region.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.